Sorry, you need to enable JavaScript to visit this website.

This website is intended for healthcare professionals in KSA and UAE only.

The content provided is developed in accordance with local regulations and may not be applicable or compliant in other regions.

This website is intended for healthcare professionals in KSA and UAE only.
 The content provided is developed in accordance with local regulations and may not be applicable or compliant in other regions.

Icon Search
hamburguer menu

Search results

hamburguer menu

High Dose Vs Low Dose IV Iron, Which One To Choose?

Overview

This lecture by Dr. Yasser Faden compares high-dose and low-dose intravenous iron therapies, discussing evidence-based recommendations and practical considerations in clinical decision-making. It provides insights on achieving optimal patient outcomes, highlighting the efficacy and convenience of modern IV iron formulations in correcting iron deficiency anemia efficiently and safely.

Dr. Yasser Faden, MD, MBBS. Associate Dean, Deanship of Postgraduate Education at King Saud bin Abdulaziz University for Health Sciences King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Jeddah, KSA Chairman, Department of Obstetrics and Gynecology & Consultant, Maternal-Fetal Medicine, Obstetrics & Gynecology. Chairman, Saudi Board Obstetrics and Gynecology Scientific Exam Committee.
Which of the following is a key advantage of high-dose FCM over low-dose FCM?
  • Reduced number of infusions
  • Lower risk of hypersensitivity reactions
  • Slower iron replenishment
  • Lower efficacy in improving hemoglobin levels
In iron deficiency anemia (IDA), high-dose FCM is typically preferred because:
  • It requires more frequent administration
  • It leads to faster iron repletion
  • It has a lower cost per infusion
  • It is less effective than low-dose FCM
A potential disadvantage of high-dose FCM compared to low-dose FCM is:
  • Increased risk of iron overload in certain patients
  • Reduced efficacy in replenishing iron stores
  • Longer infusion times
  • Higher incidence of gastrointestinal side effects
Which of the following patients would most likely benefit from high-dose FCM rather than low-dose FCM?
  • A patient with mild iron deficiency anemia and stable hemoglobin
  • A patient with chronic kidney disease (CKD) and significant iron deficiency
  • A patient with iron deficiency anemia who prefers multiple small infusions
  • A patient with iron overload disorder
What is a common reason for choosing low-dose FCM instead of high-dose FCM?
  • The patient requires rapid iron correction
  • The patient requires rapid iron correction
  • Low-dose FCM has better long-term outcomes
  • High-dose FCM is less effective

The CME certification is provided for live webinar attendance only.

GCC-FCM-2500035 I Date of preparation: October 2025